e

eureKARE

8 employees

eureKARE is focused on investing in synthetic biology biotechnology companies and creating new ventures.

Investor insights

Sectors invested in

Health Care2
Medical2
Biotechnology2
Start-up1
DNA synthesis1
Technology1
Pharmaceutical1
Data Center1
Electronics1
Data Storage1
Synthetic Biology1
Life Science1
Sciences1
Research1

Funding rounds participated in

$103M sweet spot round size

Most of their 3 investments are in rounds between $5.2M and $200M

Investor type

Venture Capital

Basic info

Industry

investment banking

Sectors

Biotechnology
Finance
Venture Capital

Date founded

2020

Investments made

B

BIOMEMORY raised $5.2M on November 28, 2022

Investors: Paris Business Angels, Prunay Impact - Startup Studio and eureKARE

D

DNA Script raised $200M on January 4, 2022

Investors: T. Rowe Price, Casdin Capital, LLC, HealthCor Management, L.P., Irving Investors, Coatue Management, HEALTHCOR LTD, Catalio Capital Management, Columbia Threadneedle Investments EMEA APAC and eureKARE

G

Gynov raised undisclosed on November 25, 2021

Investors: eureKARE

FAQ